AVIR
Atea Pharmaceuticals, Inc.
Halal Rating :
See Details
Last Price
$3.95
Last updated:
Market Cap
$312.25m
7D Change
4.59%
1 Year Change
19.08%
Company Overview
Industries
Exchange
NASDAQ
Next Earnings Date
Nov. 6, 2023
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing antiviral therapies for patients suffering from viral infections. The company is headquartered in Boston, Massachusetts.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2023 | $4.32m | $57.71m | $7.86m | $4.32m | 182.16% | 7.48% |
| June 30, 2023 | $3.7m | $52.1m | $7.3m | $3.7m | 197.54% | 7.10% |
Company Impact
Help us evaluate Atea Pharmaceuticals, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.